[1] Parash O, Hamid S.Are we ready for a new epidemic of under recognized liver disease in South Asia especially in Pasistin non alcoholic fatty liver disease[J]. J Park Med Assoc,2013,63(3):95-99. [2] Nnaji AA.Animal models of nonalcoholic fatty liver disease and steatohepatitis[J]. Clin Liver Dsi, 2004, 8(3):559-574. [3] Koteish A, Diehl AM.Animal models of steatosis[J]. Semin Liver Dis, 2001, 21(1):89-104. [4] 杨坤, 孔华丽. 脂肪肝动物实验模型的方法学研究进展[J]. 解放军药学学报, 2005, 21(5):374-376. [5] 赵敏, 陈光亮. 中药治疗非酒精性脂肪肝的实验研究进展[J]. 安徽医药, 2007, 11(3):256-257. [6] 杨威, 徐闯, 陈媛媛, 等. 大鼠非酒精性脂肪肝模型的建立[J]. 黑龙江八一农垦大学学报, 2017, 29(3):15-19. [7] 王昀, 陈蜜, 江振洲, 等. 鸡骨草总黄酮碳苷对乙硫氨酸导致的小鼠脂肪肝的影响[J]. 中国临床药理学与治疗学, 2014, 19(1):1-7. [8] 刘峰, 向志钢, 许继凡, 等. 高脂饲料结合 CCl4 诱导小鼠非酒精性脂肪肝模型的建立[J]. 江苏医药, 2010, 36(1):69-71. [9] 冯淑芝. 高脂饮食加饮酒对大鼠动脉硬化的影响[D]. 天津: 天津医科大学, 2009. [10] Wong RJ, Liu B, Bhuket T.Significant burden of nonalcoholic fatty liver disease with advanced fibrosis in the US: A cross-sectional analysis of 2011-2014 National Health and Nutrition Examination Survey[J]. Aliment Pharmacol Ther, 2017, 46(10):974-980.